WORLD ACCEPTANCE CORP
For the period ended Dec 31, 2024. Filed Feb 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Dec 31, 2024 · Filed Feb 6, 2025
Contents
Item 1. CONSOLIDATED BALANCE SHEETS
| December 31, 2024 | March 31, 2024 | |
|---|---|---|
| ASSETS | ||
| Cash and cash equivalents | $15,582,553 | $11,839,460 |
| Gross loans receivable | 1,381,461,902 | 1,277,149,256 |
| Less: | ||
| Unearned interest, insurance and fees | (361,444,148) | (326,746,136) |
| Allowance for credit losses | (116,110,946) | (102,962,811) |
| Loans receivable, net | 903,906,808 | 847,440,309 |
| Income taxes receivable | 7,188,053 | 3,091,229 |
| Operating lease right‐of‐use assets, net | 78,856,773 | 79,501,238 |
| Property and equipment, net | 20,551,225 | 22,897,197 |
| Deferred income taxes, net | 31,967,282 | 30,942,844 |
| Other assets, net | 36,775,212 | 42,198,242 |
| Goodwill | 7,370,791 | 7,370,791 |
| Intangible assets, net | 8,301,486 | 11,069,733 |
| Total assets | $1,110,500,183 | $1,056,351,043 |
| LIABILITIES & SHAREHOLDERS' EQUITY | ||
| Liabilities: | ||
| Senior notes payable | $335,949,020 | $223,419,132 |
| Senior unsecured notes payable, net | 223,910,142 | 272,609,632 |
| Operating lease liability | 81,207,297 | 81,920,865 |
| Accounts payable and accrued expenses | 41,263,775 | 53,974,198 |
| Total liabilities | 682,330,234 | 631,923,827 |
| Commitments and contingencies | ||
| Shareholders' equity: | ||
| Preferred stock, no par value Authorized 5,000,000, no shares issued or outstanding | — | — |
| Common stock, no par value Authorized 95,000,000 shares; issued and outstanding 5,787,976 and 5,938,665 shares at December 31, 2024 and March 31, 2024, respectively | — | — |
| Additional paid-in capital | 267,074,904 | 286,432,952 |
| Retained earnings | 161,095,045 | 137,994,264 |
| Total shareholders' equity | 428,169,949 | 424,427,216 |
| Total liabilities and shareholders' equity | $1,110,500,183 | $1,056,351,043 |
CONSOLIDATED STATEMENTS OF OPERATIONS
| Three months ended December 31, | Nine months ended December 31, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Revenues: | ||||
| Interest and fee income | $122,390,403 | $118,665,105 | $347,456,761 | $352,237,133 |
| Insurance and other income, net | 16,242,350 | 19,084,282 | 52,112,762 | 61,711,366 |
| Total revenues | 138,632,753 | 137,749,387 | 399,569,523 | 413,948,499 |
| Expenses: | ||||
| Provision for credit losses | 44,103,495 | 40,631,994 | 136,191,023 | 127,697,072 |
| General and administrative expenses: | ||||
| Personnel | 41,074,877 | 39,890,187 | 99,804,998 | 120,119,638 |
| Occupancy and equipment | 12,293,093 | 12,090,198 | 36,793,516 | 37,138,444 |
| Advertising | 4,448,074 | 3,721,155 | 8,925,597 | 8,712,406 |
| Amortization of intangible assets | 938,026 | 1,050,926 | 2,902,848 | 3,182,805 |
| Other | 8,468,838 | 9,156,841 | 26,563,688 | 27,828,730 |
| Total general and administrative expenses | 67,222,908 | 65,909,307 | 174,990,647 | 196,982,023 |
| Interest expense | 11,293,874 | 11,689,924 | 31,520,066 | 36,475,411 |
| Total expenses | 122,620,277 | 118,231,225 | 342,701,736 | 361,154,506 |
| Income before income taxes | 16,012,476 | 19,518,162 | 56,867,787 | 52,793,993 |
| Income tax expense | 2,624,180 | 2,853,344 | 11,403,906 | 10,508,008 |
| Net income | $13,388,296 | $16,664,818 | $45,463,881 | $42,285,985 |
| Net income per common share: | ||||
| Basic | $2.46 | $2.89 | $8.32 | $7.32 |
| Diluted | $2.45 | $2.84 | $8.23 | $7.17 |
| Weighted average common shares outstanding: | ||||
| Basic | 5,436,688 | 5,772,503 | 5,461,990 | 5,775,108 |
| Diluted | 5,464,217 | 5,860,117 | 5,526,784 | 5,896,716 |
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
| Three months ended December 31, 2024 | ||||
|---|---|---|---|---|
| Common Stock | ||||
| Shares | Additional Paid-in Capital | Retained Earnings | Total Shareholders' Equity | |
| Balances at September 30, 2024 | 5,769,530 | $268,746,030 | $148,717,724 | $417,463,754 |
| Proceeds from exercise of stock options | 5,324 | 424,420 | — | 424,420 |
| Common stock repurchases | (9,465) | — | (1,010,975) | (1,010,975) |
| Stock-based compensation (reversal) related to restricted stock, net of cancellations ($2,544,812) | 22,587 | (2,181,186) | — | (2,181,186) |
| Stock-based compensation related to stock options | — | 85,640 | — | 85,640 |
| Net income | — | — | 13,388,296 | 13,388,296 |
| Balances at December 31, 2024 | 5,787,976 | $267,074,904 | $161,095,045 | $428,169,949 |
| Three months ended December 31, 2023 | ||||
|---|---|---|---|---|
| Common Stock | ||||
| Shares | Additional Paid-in Capital | Retained Earnings | Total Shareholders' Equity | |
| Balances at September 30, 2023 | 6,246,818 | $287,246,730 | $122,776,065 | $410,022,795 |
| Proceeds from exercise of stock options | 11,104 | 948,441 | — | 948,441 |
| Common stock repurchases | (148,765) | — | (17,291,997) | (17,291,997) |
| Stock-based compensation (reversal) related to restricted stock, net of cancellations ($2,823,774) | (35,858) | (3,514,473) | — | (3,514,473) |
| Stock-based compensation related to stock options | — | 189,582 | — | 189,582 |
| Net income | — | — | 16,664,818 | 16,664,818 |
| Balances at December 31, 2023 | 6,073,299 | $284,870,280 | $122,148,886 | $407,019,166 |
| Nine months ended December 31, 2024 | ||||
|---|---|---|---|---|
| Common Stock | ||||
| Shares | Additional Paid-in Capital | Retained Earnings | Total Shareholders' Equity | |
| Balances at March 31, 2024 | 5,938,665 | $286,432,952 | $137,994,264 | $424,427,216 |
| Proceeds from exercise of stock options | 20,310 | 1,881,436 | — | 1,881,436 |
| Common stock repurchases | (174,632) | — | (22,363,100) | (22,363,100) |
| Stock-based compensation (reversal) related to restricted stock, net of cancellations ($2,676,053) | 3,633 | (21,562,624) | — | (21,562,624) |
| Stock-based compensation related to stock options | — | 323,140 | — | 323,140 |
| Net income | — | — | 45,463,881 | 45,463,881 |
| Balances at December 31, 2024 | 5,787,976 | $267,074,904 | $161,095,045 | $428,169,949 |
| Nine months ended December 31, 2023 | ||||||
|---|---|---|---|---|---|---|
| Common Stock | ||||||
| Shares · Additional Paid-in Capital · Retained Earnings · Total Shareholders' Equity | ||||||
| Balances at March 31, 2023 | 6,231,082 | $288,071,839 | $97,154,898 | $385,226,737 | ||
| Proceeds from exercise of stock options | 22,847 | 2,018,412 | — | 2,018,412 | ||
| Common stock repurchases | (148,765) | (17,291,997) | (17,291,997) | |||
| Stock-based compensation (reversal) related to restricted stock, net of cancellations ($2,823,774) | (31,865) | (1,348,623) | — | (1,348,623) | ||
| Stock-based compensation (reversal) related to stock options | — | (3,871,348) | — | (3,871,348) | ||
| Net income | — | — | 42,285,985 | 42,285,985 | ||
| Balances at December 31, 2023 | 6,073,299 | $284,870,280 | $122,148,886 | $407,019,166 | ||
CONSOLIDATED STATEMENTS OF CASH FLOWS
| Nine months ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash flow from operating activities: | ||
| Net income | $45,463,881 | $42,285,985 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Amortization of intangible assets | 2,902,848 | 3,182,805 |
| Accrued unearned interest | (4,437,733) | (4,225,244) |
| Amortization of deferred loan cost | 10,461,809 | 10,285,733 |
| Gain on extinguishment of senior unsecured notes payable | (1,160,067) | (1,162,581) |
| Amortization of debt issuance costs | 999,688 | 1,338,352 |
| Amortization of discount on loans acquired in an asset purchase | (380,232) | — |
| Provision for credit losses | 136,191,023 | 127,697,072 |
| Depreciation | 4,799,367 | 4,937,169 |
| Gain on sale of property and equipment | (78,011) | (95,621) |
| Deferred income tax expense (benefit) | (1,024,438) | 4,674,792 |
| Stock-based compensation (reversal) related to equity classified awards | (18,563,431) | (2,396,197) |
| Change in accounts: | ||
| Other assets, net | 5,007,294 | 5,213,994 |
| Income taxes receivable | (4,096,824) | (4,249,555) |
| Accounts payable and accrued expenses | (12,878,833) | (5,516,759) |
| Net cash provided by operating activities | 163,206,341 | 181,969,945 |
| Cash flows from investing activities: | ||
| Increase in loans receivable, net | (179,488,673) | (153,198,324) |
| Cash paid for acquisitions, primarily loans | (18,947,294) | — |
| Purchases of property and equipment | (2,814,437) | (4,419,445) |
| Proceeds from the sale of property and equipment | 439,053 | 308,174 |
| Net cash used in investing activities | (200,811,351) | (157,309,595) |
| Cash flow from financing activities: | ||
| Borrowings from senior notes payable | 297,385,341 | 215,066,622 |
| Payments on senior notes payable | (184,855,453) | (217,887,966) |
| Payments for extinguished senior unsecured notes payable | (48,148,250) | (6,978,717) |
| Payments for debt extinguishment costs | (12,500) | (20,625) |
| Debt issuance costs associated with senior notes payable | (31,728) | (475,716) |
| Proceeds from exercise of stock options | 1,881,436 | 2,018,412 |
| Payments for taxes related to net share settlement of equity awards | (2,676,053) | (2,823,774) |
| Repurchase of common stock | (22,194,690) | (17,291,997) |
| Net cash provided by (used in) financing activities | 41,348,103 | (28,393,761) |
| Net change in cash and cash equivalents | 3,743,093 | (3,733,411) |
| Cash and cash equivalents at beginning of period | 11,839,460 | 16,508,935 |
| Cash and cash equivalents at end of period | $15,582,553 | $12,775,524 |
| Supplemental Disclosures: | ||
| Interest paid during the period | $36,476,307 | $41,233,947 |
| Income taxes paid during the period | $3,204,509 | $7,726,889 |
| Excise tax on stock repurchases not paid during the period | $168,410 | $— |
WORLD ACCEPTANCE CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 –BASIS OF PRESENTATION
The consolidated financial statements of the Company at December 31, 2024 and 2023 and for the three and nine months then ended were prepared in accordance with the instructions for Form 10-Q and are unaudited; however, in the opinion of management, all adjustments (consisting only of items of a normal, recurring nature) necessary for a fair presentation of the financial position at December 31, 2024, and the results of operations and cash flows for the periods ended December 31, 2024 and 2023, have been included. The results for the interim periods are not necessarily indicative of the results that may be expected for the full year or any other interim period.
The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amount of revenue and expenses during the reporting period. Actual results could differ from those estimates.
The consolidated financial statements do not include all disclosures required by GAAP and should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the fiscal year ended March 31, 2024, included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2024, as filed with the SEC (the "fiscal 2024 Annual Report"). The Company applies the accounting policies contained in Note 1 to the Consolidated Financial Statements included in fiscal 2024 Annual Report. The Company believes that the disclosures are adequate to make the information presented not misleading.
NOTE 2 –SUMMARY OF SIGNIFICANT POLICIES
Nature of Operations
The Company is a small-loan consumer finance company headquartered in Greenville, South Carolina that offers short-term small loans, medium-term larger loans, related credit insurance products and ancillary products and services to individuals who have limited access to other sources of consumer credit. The Company offers income tax return preparation services to its loan customers and other individuals.
Seasonality
The Company's loan volume and corresponding loans receivable follow seasonal trends. The Company's highest loan demand generally occurs from October through December, its third fiscal quarter. Loan demand is generally lowest and loan repayment highest from January to March, its fourth fiscal quarter. Loan volume and average balances remain relatively level during the remainder of the year. Consequently, the Company experiences significant seasonal fluctuations in its operating results and cash needs. Operating results for the Company's third fiscal quarter are generally lower than in other quarters, and operating results for its fourth fiscal quarter are generally higher than in other quarters.
Loans receivable, net
Loans receivable are carried at amortized cost, which is the gross amount outstanding, reduced by unearned interest and insurance income, net of deferred origination fees and direct costs, and an allowance for credit losses. Fees received and direct costs incurred for the origination of loans are deferred and amortized to interest income over the contractual lives of the loans using the interest method. Unamortized amounts are recognized in income at the time that loans are refinanced or paid in full except for those refinancings that do not constitute a more than minor modification. Net unamortized deferred origination costs were $6.6 million and $5.0 million as of December 31, 2024 and March 31, 2024, respectively.
From time to time, the Company will sell charged off loans receivable, which are accounted for as a sale in accordance with ASC 860, Transfers and Servicing. See Note 4 to the Consolidated Financial Statements for further information.
Allowance for credit losses
Refer to Note 4 to the Consolidated Financial Statements for information regarding the Company's CECL allowance model and a description of the policies and methodology utilized.
Reclassification
From time to time, prior period amounts will be reclassified to conform to the current presentation. Such reclassifications have no impact on previously reported net income or shareholders' equity.
Recently Issued Accounting Standards Not Yet Adopted
Improvements to Reportable Segment Disclosures
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments are effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied retrospectively to all prior periods presented in the financial statements. Management is currently evaluating this ASU to determine its impact on the Company's consolidated financial statements and related disclosures.
Improvements to Income Tax Disclosures
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which modifies the rules on income tax disclosures to require entities to expand annual disclosures to 1) include specific categories in the rate reconciliation and additional information for reconciling items that meet a quantitative threshold and 2) disclose the amount of income taxes paid (net of refunds received) disaggregated by federal, state and foreign taxes. ASU 2023-09 also requires entities to disclose income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign, and income tax expense (or benefit) from continuing operations disaggregated by federal, state and foreign, among other changes. The amendments are effective for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. Management is currently evaluating this ASU to determine its impact on the Company's consolidated financial statements and related disclosures.
Disaggregation of Income Statement Expenses
In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses, which requires additional disclosure, in the notes to financial statements, about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses. The amendments in this update are effective for annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027, which was clarified by ASU 2025-01, Clarifying the Effective Date. Early adoption is permitted. ASU 2024-03 should be applied either (1) prospectively to financial statements issued for reporting periods after the effective date of this update or (2) retrospectively to any or all prior periods presented in the financial statements. Management is currently evaluating this ASU to determine its impact on the Company's consolidated financial statements and related disclosures.
We reviewed all other newly issued accounting pronouncements and concluded that they are either not applicable to our business or are not expected to have a material effect on the consolidated financial statements and related disclosures as a result of future adoption.
NOTE 3 –FAIR VALUE
Fair Value Disclosures
The Company may carry certain financial instruments and derivative assets and liabilities at fair value measured on a recurring or nonrecurring basis. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date. The Company measures the fair values of its financial instruments based on the fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.
Fair value measurements are grouped in three levels. The levels prioritize the inputs used to measure the fair value of the assets or liabilities. These levels are:
Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2 – Inputs other than quoted prices that are observable for assets and liabilities, either directly or indirectly. These inputs include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are less active.
Level 3 – Unobservable inputs for assets or liabilities reflecting the reporting entity’s own assumptions.
The Company’s financial instruments consist of cash and cash equivalents, loans receivable, net, the senior notes payable, and the senior unsecured notes payable. Loans receivable are originated at prevailing market rates and have an average life of up to twelve months. Given the short-term nature of these loans, they are continually repriced at current market rates. The Company’s senior notes payable, consisting of a senior revolving credit facility, has a variable rate based on a margin over SOFR and reprices with any changes in SOFR. The fair value of the senior unsecured notes payable is estimated based on quoted prices in markets that are not active. The Company also considers its creditworthiness in its estimation of fair value.
The carrying amounts and estimated fair values of financial assets and liabilities disclosed but not carried at fair value and their level within the fair value hierarchy are summarized below.
| December 31, 2024 · March 31, 2024 | |||||
|---|---|---|---|---|---|
| Input Level | Carrying Value | Estimated Fair Value | Carrying Value | Estimated Fair Value | |
| ASSETS | |||||
| Cash and cash equivalents | 1 | $15,582,553 | $15,582,553 | $11,839,460 | $11,839,460 |
| Loans receivable, net | 3 | 903,906,808 | 903,906,808 | 847,440,309 | 847,440,309 |
| LIABILITIES | |||||
| Senior unsecured notes payable, net | 2 | 223,910,142 | 222,969,719 | 272,609,632 | 254,208,482 |
| Senior notes payable | 3 | 335,949,020 | 335,949,020 | 223,419,132 | 223,419,132 |
There were no significant assets or liabilities measured at fair value on a non-recurring basis as of December 31, 2024 or March 31, 2024.
NOTE 4 –LOANS RECEIVABLE AND ALLOWANCE FOR CREDIT LOSSES
The following is a summary of gross loans receivable by Customer Tenure as of:
| Customer Tenure | December 31, 2024 | March 31, 2024 |
|---|---|---|
| 0 to 5 months | $120,206,225 | $73,699,568 |
| 6 to 17 months | 83,792,574 | 69,616,739 |
| 18 to 35 months | 119,019,301 | 140,340,728 |
| 36 to 59 months | 152,290,291 | 181,399,293 |
| 60+ months | 904,874,073 | 799,703,920 |
| TALs | 1,279,438 | 12,389,008 |
| Total gross loans | $1,381,461,902 | $1,277,149,256 |
Current payment performance is used to assess the capability of the borrower to repay contractual obligations of the loan agreements as scheduled, which is monitored by management on a daily basis. The Company’s payment performance buckets are as follows: current, 30-60 days past due, 61-90 days past due, 91 days or more past due.
All loans, except for TALs, that are greater than 90 days past due on a recency basis and not written off as of the reporting date are reserved for at 100% of the outstanding balance, net of a calculated Rehab Rate. The weighted average Rehab Rate at December 31, 2024 and March 31, 2024 was 4.7% and 4.9%, respectively. A loan is charged off within the allowance for credit losses in the month following when an account reaches 120 days past due on a recency basis, subject to certain exceptions. Specifically, the Company’s customer accounts in a confirmed bankruptcy are generally charged off in the month after they reach 60 days past due on a recency basis. The accounts of deceased or incarcerated customers are also generally charged off in the month after they reach 60 days past due on a recency basis, with the exception of deceased customers with credit life insurance. Subsequent recoveries of amounts charged off, if any, are credited to the allowance for credit losses.
The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a recency basis and year of origination at December 31, 2024:
| Term Loans By Origination | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Loans · Up to1Year Ago · Between1 and 2Years Ago · Between2 and 3Years Ago · Between3 and 4Years Ago · Between4 and 5Years Ago · More than5Years Ago · Total | ||||||||||
| Current | $1,191,801,595 | $53,796,457 | $5,232,034 | $246,907 | $5,097 | $4,612 | $1,251,086,702 | |||
| 30 - 60 days past due | 45,078,425 | 5,587,931 | 771,319 | 88,677 | 5,498 | 12,712 | 51,544,562 | |||
| 61 - 90 days past due | 27,968,712 | 3,192,929 | 387,807 | 46,475 | 5,912 | 518 | 31,602,353 | |||
| 91 or more days past due | 38,928,934 | 6,353,121 | 611,384 | 52,719 | 2,689 | — | 45,948,847 | |||
| Total | $1,303,777,666 | $68,930,438 | $7,002,544 | $434,778 | $19,196 | $17,842 | $1,380,182,464 | |||
| Term Loans By Origination | ||||||||||
| TALs | Up to1Year Ago | Between1 and 2Years Ago | Between2 and 3Years Ago | Between3 and 4Years Ago | Between4 and 5Years Ago | More than5Years Ago | Total | |||
| Current | $191,926 | $— | $— | $— | $— | $— | $191,926 | |||
| 30 - 60 days past due | 71,880 | — | — | — | — | — | 71,880 | |||
| 61 - 90 days past due | 56,193 | — | — | — | — | — | 56,193 | |||
| 91 or more days past due | 959,439 | — | — | — | — | — | 959,439 | |||
| Total | $1,279,438 | $— | $— | $— | $— | $— | $1,279,438 | |||
| Total gross loans | $1,381,461,902 | |||||||||
The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a recency basis and year of origination at March 31, 2024:
| Term Loans By Origination | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Loans · Up to1Year Ago · Between1 and 2Years Ago · Between2 and 3Years Ago · Between3 and 4Years Ago · Between4 and 5Years Ago · More than5Years Ago · Total | ||||||||||
| Current | $1,094,896,350 | $61,853,967 | $4,807,924 | $109,050 | $25,850 | $1,371 | $1,161,694,512 | |||
| 30 - 60 days past due | 34,034,537 | 4,600,615 | 610,649 | 10,856 | 14,076 | 5,429 | 39,276,162 | |||
| 61 - 90 days past due | 21,874,701 | 2,154,561 | 200,117 | 17,493 | 204 | — | 24,247,076 | |||
| 91 or more days past due | 34,560,868 | 4,600,040 | 364,386 | 6,151 | 5,617 | 5,436 | 39,542,498 | |||
| Total | $1,185,366,456 | $73,209,183 | $5,983,076 | $143,550 | $45,747 | $12,236 | $1,264,760,248 | |||
| Term Loans By Origination | ||||||||||
| TALs | Up to1Year Ago | Between1 and 2Years Ago | Between2 and 3Years Ago | Between3 and 4Years Ago | Between4 and 5Years Ago | More than5Years Ago | Total | |||
| Current | $7,441,660 | $860 | $— | $— | $— | $— | $7,442,520 | |||
| 30 - 60 days past due | 4,942,757 | 788 | — | — | — | — | 4,943,545 | |||
| 61 - 90 days past due | — | 1,650 | — | — | — | — | 1,650 | |||
| 91 or more days past due | — | 1,293 | — | — | — | — | 1,293 | |||
| Total | $12,384,417 | $4,591 | $— | $— | $— | $— | $12,389,008 | |||
| Total gross loans | $1,277,149,256 | |||||||||
The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a contractual basis and year of origination at December 31, 2024:
| Term Loans By Origination | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Loans · Up to1Year Ago · Between1 and 2Years Ago · Between2 and 3Years Ago · Between3 and 4Years Ago · Between4 and 5Years Ago · More than5Years Ago · Total | ||||||||||
| Current | $1,179,892,149 | $47,643,195 | $4,032,753 | $130,939 | $— | $— | $1,231,699,036 | |||
| 30 - 60 days past due | 46,938,294 | 4,289,434 | 347,554 | 10,189 | — | 4,836 | 51,590,307 | |||
| 61 - 90 days past due | 30,851,070 | 3,357,138 | 300,261 | 20,307 | 205 | — | 34,528,981 | |||
| 91 or more days past due | 46,096,156 | 13,640,670 | 2,321,974 | 273,343 | 18,991 | 13,006 | 62,364,140 | |||
| Total | $1,303,777,669 | $68,930,437 | $7,002,542 | $434,778 | $19,196 | $17,842 | $1,380,182,464 | |||
| Term Loans By Origination | ||||||||||
| TALs | Up to1Year Ago | Between1 and 2Years Ago | Between2 and 3Years Ago | Between3 and 4Years Ago | Between4 and 5Years Ago | More than5Years Ago | Total | |||
| Current | $158,737 | $— | $— | $— | $— | $— | $158,737 | |||
| 30 - 60 days past due | 50,553 | — | — | — | — | — | 50,553 | |||
| 61 - 90 days past due | 37,596 | — | — | — | — | — | 37,596 | |||
| 91 or more days past due | 1,032,552 | — | — | — | — | — | 1,032,552 | |||
| Total | $1,279,438 | $— | $— | $— | $— | $— | $1,279,438 | |||
| Total gross loans | $1,381,461,902 | |||||||||
The following table provides a breakdown of the Company’s gross loans receivable by current payment performance on a contractual basis and year of origination at March 31, 2024:
| Term Loans By Origination | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Loans · Up to1Year Ago · Between1 and 2Years Ago · Between2 and 3Years Ago · Between3 and 4Years Ago · Between4 and 5Years Ago · More than5Years Ago · Total | ||||||||||
| Current | $1,079,720,968 | $54,770,231 | $3,681,104 | $39,921 | $10,484 | $1,371 | $1,138,224,079 | |||
| 30 - 60 days past due | 37,475,784 | 3,388,380 | 288,576 | 1,064 | — | — | 41,153,804 | |||
| 61 - 90 days past due | 26,191,269 | 2,903,253 | 208,172 | 3,430 | 204 | — | 29,306,328 | |||
| 91 or more days past due | 41,978,436 | 12,147,320 | 1,805,223 | 99,134 | 35,059 | 10,865 | 56,076,037 | |||
| Total | $1,185,366,457 | $73,209,184 | $5,983,075 | $143,549 | $45,747 | $12,236 | $1,264,760,248 | |||
| Term Loans By Origination | ||||||||||
| TALs | Up to1Year Ago | Between1 and 2Years Ago | Between2 and 3Years Ago | Between3 and 4Years Ago | Between4 and 5Years Ago | More than5Years Ago | Total | |||
| Current | $7,441,661 | $— | $— | $— | $— | $— | $7,441,661 | |||
| 30 - 60 days past due | 4,942,757 | — | — | — | — | — | 4,942,757 | |||
| 61 - 90 days past due | — | — | — | — | — | — | — | |||
| 91 or more days past due | — | 4,590 | — | — | — | — | 4,590 | |||
| Total | $12,384,418 | $4,590 | $— | $— | $— | $— | $12,389,008 | |||
| Total gross loans | $1,277,149,256 | |||||||||
The following table provides a breakdown of the Company’s gross charge-offs by fiscal year of origination for the three and nine months ended December 31, 2024:
| Three months ended December 31, · Nine months ended December 31, | ||||||
|---|---|---|---|---|---|---|
| Gross Charge-offs by Origination · Gross Charge-offs by Origination | ||||||
| Origination Year | Loans | TALs | Total | Loans | TALs | Total |
| 2020 and prior | $— | $— | $— | $24,919 | $— | $24,919 |
| 2021 | 2,675 | — | 2,675 | 26,161 | — | 26,161 |
| 2022 | 148,994 | — | 148,994 | 708,565 | — | 708,565 |
| 2023 | 1,463,591 | — | 1,463,591 | 8,571,378 | 175 | 8,571,553 |
| 2024 | 23,325,438 | 651,498 | 23,976,936 | 103,377,399 | 2,814,391 | 106,191,790 |
| 2025 | 23,230,774 | — | 23,230,774 | 23,867,489 | — | 23,867,489 |
| Total | $48,171,472 | $651,498 | $48,822,970 | $136,575,911 | $2,814,566 | $139,390,477 |
The following table provides a breakdown of the Company’s gross charge-offs by fiscal year of origination for the three and nine months ended December 31, 2023:
| Three months ended December 31, · Nine months ended December 31, | ||||||
|---|---|---|---|---|---|---|
| Gross Charge-offs by Origination · Gross Charge-offs by Origination | ||||||
| Origination Year | Loans | TALs | Total | Loans | TALs | Total |
| 2019 and prior | $1,958 | $— | $1,958 | $11,385 | $— | $11,385 |
| 2020 | 3,909 | — | 3,909 | 33,560 | — | 33,560 |
| 2021 | 44,632 | — | 44,632 | 275,558 | — | 275,558 |
| 2022 | 1,660,567 | 188 | 1,660,755 | 10,243,978 | 5,197 | 10,249,175 |
| 2023 | 28,683,289 | 118,287 | 28,801,576 | 120,931,950 | 1,260,273 | 122,192,223 |
| 2024 | 24,222,152 | — | 24,222,152 | 24,466,713 | — | 24,466,713 |
| Total | $54,616,507 | $118,475 | $54,734,982 | $155,963,144 | $1,265,470 | $157,228,614 |
Credit risk is inherent in the business of extending loans to borrowers and is continuously monitored by management and reflected within the allowance for credit losses for loans. The allowance for credit losses is an estimate of expected losses inherent within the Company’s gross loans receivable portfolio. In estimating the allowance for credit losses, loans with similar risk characteristics are aggregated into pools and collectively assessed. The Company’s loan products have generally the same terms therefore the Company looks to borrower characteristics as a way to disaggregate loans into pools sharing similar risks.
In determining the allowance for credit losses, the Company examined four borrower risk metrics as noted below.
Borrower type
Active months
Prior loan performance
Customer Tenure
To determine how well each metric predicts default risk the Company used loss rate data over an observation period of twelve months at the loan level.
The information value was then calculated for each metric. From this analysis management determined the metric that had the strongest predictor of default risk was Customer Tenure. The Customer Tenure buckets used in the allowance for credit loss calculation are:
1.0 to 5 months
2.6 to 17 months
3.18 to 35 months
4.36 to 59 months
5.60+ months
Management will continue to monitor this credit metric on a quarterly basis.
Management estimates an allowance for each Customer Tenure bucket by performing a historical migration analysis of loans in that bucket for the twelve most recent historical twelve-month migration periods. Management considers whether current credit conditions might suggest a change is needed to the allowance for credit losses by monitoring trends in first pay success for new borrowers, 60-89 day delinquencies on a recency basis, percent of loan balances that are paying and percentage of gross loans that are acquired loans. If management determines that historical migration rates should be adjusted to reflect expected credit losses, a qualitative adjustment is made to reflect management's judgment regarding observable changes in recent or expected economic trends and conditions, portfolio composition, or other significant events or conditions that affect the current estimate. The increase in the allowance for credit losses from March 31, 2024 to December 31, 2024 was primarily due to loan growth during the period.
Due to the short term nature of the loan portfolio, forecasted changes in macroeconomic variables such as unemployment levels, general inflation and commodity prices, typically do not have a significant impact on loans outstanding at the end of a particular reporting period, unless those changes are particularly severe and sudden in nature. Therefore, management develops a reasonable and supportable forecast of losses by comparing the most recent six-month loss curves as compared to historical loss curves to see if there are significant changes in borrower behavior that may indicate the historical migration rates should be adjusted. If a change is determined necessary, then the Company has elected to immediately revert back to historical experience past the forecast period. As of December 31, 2024 and March 31, 2024, there were no conditions or other factors considered significant enough to warrant a forecast adjustment.
The following table presents a roll forward of the allowance for credit losses for the three and nine months ended December 31, 2024 and 2023:
| Three months ended December 31, | Nine months ended December 31, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Beginning balance | $114,455,495 | $128,892,192 | $102,962,811 | $125,552,733 |
| Provision for credit losses | 44,103,495 | 40,631,994 | 136,191,023 | 127,697,072 |
| Charge-offs | (48,822,970) | (54,734,982) | (139,390,477) | (157,228,614) |
| Recoveries1 | 6,374,926 | 6,292,864 | 16,347,589 | 25,060,877 |
| Net charge-offs | (42,448,044) | (48,442,118) | (123,042,888) | (132,167,737) |
| Ending Balance | $116,110,946 | $121,082,068 | $116,110,946 | $121,082,068 |
The following table is an aging analysis on a recency basis at amortized cost of the Company’s gross loans receivable at December 31, 2024:
| Days Past Due - Recency Basis | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Customer Tenure | Current | 30 - 60 | 61 - 90 | Over 90 | Total Past Due | Total Loans | |||
| 0 to 5 months | $97,729,708 | $8,178,732 | $5,850,084 | $8,447,701 | $22,476,517 | $120,206,225 | |||
| 6 to 17 months | 71,894,285 | 4,123,710 | 2,957,998 | 4,816,581 | 11,898,289 | 83,792,574 | |||
| 18 to 35 months | 104,818,028 | 5,232,991 | 3,486,649 | 5,481,633 | 14,201,273 | 119,019,301 | |||
| 36 to 59 months | 135,845,513 | 6,391,258 | 3,906,289 | 6,147,231 | 16,444,778 | 152,290,291 | |||
| 60+ months | 840,799,168 | 27,617,871 | 15,401,333 | 21,055,701 | 64,074,905 | 904,874,073 | |||
| TALs | 191,926 | 71,880 | 56,193 | 959,439 | 1,087,512 | 1,279,438 | |||
| Total gross loans | 1,251,278,628 | 51,616,442 | 31,658,546 | 46,908,286 | 130,183,274 | 1,381,461,902 | |||
| Unearned interest, insurance and fees | (331,428,164) | (9,525,813) | (8,350,208) | (12,139,963) | (30,015,984) | (361,444,148) | |||
| Total net loans | $919,850,464 | $42,090,629 | $23,308,338 | $34,768,323 | $100,167,290 | $1,020,017,754 | |||
| Percentage of period-end gross loans receivable | 3.7% | 2.3% | 3.4% | 9.4% | |||||
The following table is an aging analysis on a recency basis at amortized cost of the Company’s gross loans receivable at March 31, 2024:
1 Recoveries during the three months ended December 31, 2024 include $2.6 million and $1.5 million in proceeds related to the recurring sales of charge-offs and bulk sale of charge-offs from prior periods, respectively. Recoveries during the nine months ended December 31, 2024 include $7.6 million and $1.5 million in proceeds related to the recurring sales of charge-offs and bulk sale of charge-offs from prior periods, respectively. Recoveries during the three months ended December 31, 2023 include $2.9 million and $0.8 million in proceeds related to the recurring sales of charge-offs and bulk sale of charge-offs from prior periods, respectively. Recoveries during the nine months ended December 31, 2023 include $10.5 million and $5.7 million in proceeds related to the recurring sales of charge-offs and bulk sale of charge-offs from prior periods, respectively. These proceeds are included as a component of Provision for credit losses in the Consolidated Statements of Operations.
| Days Past Due - Recency Basis | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Customer Tenure | Current | 30 - 60 | 61 - 90 | Over 90 | Total Past Due | Total Loans | |||
| 0 to 5 months | $56,802,704 | $4,720,149 | $4,496,518 | $7,680,197 | $16,896,864 | $73,699,568 | |||
| 6 to 17 months | 60,634,735 | 3,155,423 | 2,075,608 | 3,750,973 | 8,982,004 | 69,616,739 | |||
| 18 to 35 months | 126,843,010 | 5,057,256 | 3,224,662 | 5,215,800 | 13,497,718 | 140,340,728 | |||
| 36 to 59 months | 165,694,013 | 6,159,335 | 3,519,743 | 6,026,202 | 15,705,280 | 181,399,293 | |||
| 60+ months | 751,720,050 | 20,183,999 | 10,930,545 | 16,869,326 | 47,983,870 | 799,703,920 | |||
| TALs | 7,442,520 | 4,943,545 | 1,650 | 1,293 | 4,946,488 | 12,389,008 | |||
| Total gross loans | 1,169,137,032 | 44,219,707 | 24,248,726 | 39,543,791 | 108,012,224 | 1,277,149,256 | |||
| Unearned interest, insurance and fees | (301,616,958) | (7,677,494) | (6,674,554) | (10,777,130) | (25,129,178) | (326,746,136) | |||
| Total net loans | $867,520,074 | $36,542,213 | $17,574,172 | $28,766,661 | $82,883,046 | $950,403,120 | |||
| Percentage of period-end gross loans receivable | 3.5% | 1.9% | 3.1% | 8.5% | |||||
The following table is an aging analysis on a contractual basis at amortized cost of the Company’s gross loans receivable at December 31, 2024:
| Days Past Due - Contractual Basis | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Customer Tenure | Current | 30 - 60 | 61 - 90 | Over 90 | Total Past Due | Total Loans | |||
| 0 to 5 months | $97,003,231 | $8,063,335 | $5,874,364 | $9,265,295 | $23,202,994 | $120,206,225 | |||
| 6 to 17 months | 70,860,586 | 4,036,915 | 2,987,142 | 5,907,931 | 12,931,988 | 83,792,574 | |||
| 18 to 35 months | 102,558,371 | 5,188,437 | 3,806,830 | 7,465,663 | 16,460,930 | 119,019,301 | |||
| 36 to 59 months | 133,059,756 | 6,150,175 | 4,191,450 | 8,888,910 | 19,230,535 | 152,290,291 | |||
| 60+ months | 828,217,092 | 28,151,445 | 17,669,195 | 30,836,341 | 76,656,981 | 904,874,073 | |||
| TALs | 158,737 | 50,553 | 37,596 | 1,032,552 | 1,120,701 | 1,279,438 | |||
| Total gross loans | 1,231,857,773 | 51,640,860 | 34,566,577 | 63,396,692 | 149,604,129 | 1,381,461,902 | |||
| Unearned interest, insurance and fees | (327,330,320) | (8,969,250) | (9,101,669) | (16,042,909) | (34,113,828) | (361,444,148) | |||
| Total net loans | $904,527,453 | $42,671,610 | $25,464,908 | $47,353,783 | $115,490,301 | $1,020,017,754 | |||
| Percentage of period-end gross loans receivable | 3.7% | 2.5% | 4.6% | 10.8% | |||||
The following table is an aging analysis on a contractual basis at amortized cost of the Company’s gross loans receivable at March 31, 2024:
| Days Past Due - Contractual Basis | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Customer Tenure | Current | 30 - 60 | 61 - 90 | Over 90 | Total Past Due | Total Loans | |||
| 0 to 5 months | $55,572,691 | $4,645,860 | $4,784,273 | $8,696,744 | $18,126,877 | $73,699,568 | |||
| 6 to 17 months | 58,920,283 | 2,990,455 | 2,364,202 | 5,341,799 | 10,696,456 | 69,616,739 | |||
| 18 to 35 months | 123,878,546 | 5,246,778 | 3,813,284 | 7,402,120 | 16,462,182 | 140,340,728 | |||
| 36 to 59 months | 161,614,270 | 6,388,791 | 4,435,367 | 8,960,865 | 19,785,023 | 181,399,293 | |||
| 60+ months | 738,238,289 | 21,881,920 | 13,909,202 | 25,674,509 | 61,465,631 | 799,703,920 | |||
| TALs | 7,441,661 | 4,942,757 | — | 4,590 | 4,947,347 | 12,389,008 | |||
| Total gross loans | 1,145,665,740 | 46,096,561 | 29,306,328 | 56,080,627 | 131,483,516 | 1,277,149,256 | |||
| Unearned interest, insurance and fees | (296,584,056) | (7,544,366) | (7,936,622) | (14,681,092) | (30,162,080) | (326,746,136) | |||
| Total net loans | $849,081,684 | $38,552,195 | $21,369,706 | $41,399,535 | $101,321,436 | $950,403,120 | |||
| Percentage of period-end gross loans receivable | 3.6% | 2.3% | 4.4% | 10.3% | |||||
The Company elected not to record an allowance for credit losses for accrued interest as outlined in ASC 326-20-30-5A. Loans are placed on nonaccrual status when management determines that the full payment of principal and collection of interest according to contractual terms is no longer likely. The accrual of interest is discontinued when a loan is 61 days or more past the contractual due date. When the interest accrual is discontinued, all unpaid accrued interest is reversed against interest income. While a loan is on nonaccrual status, interest income is recognized only when a payment is received. Once a loan moves to nonaccrual status, it remains in nonaccrual status until it is paid out, charged off or refinanced.
The following table presents unpaid accrued interest reversed against interest income by Customer Tenure for the three and nine months ended December 31, 2024 and 2023:
| Three months ended December 31, | Nine months ended December 31, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Customer Tenure | ||||
| 0 to 5 months | $(1,513,556) | $(1,364,409) | $(3,943,143) | $(3,910,003) |
| 6 to 17 months | (802,513) | (779,642) | (2,201,034) | (2,653,697) |
| 18 to 35 months | (789,715) | (949,250) | (2,378,004) | (2,612,375) |
| 36 to 59 months | (829,641) | (1,068,613) | (2,553,282) | (3,214,245) |
| 60+ months | (3,227,592) | (2,828,677) | (8,869,807) | (7,977,412) |
| Total | $(7,163,017) | $(6,990,591) | $(19,945,270) | $(20,367,732) |
The following table presents the amortized cost basis of loans on nonaccrual status as of the beginning of the reporting period and the end of the reporting period, as well as interest income recognized on nonaccrual loans for the three and nine months ended December 31, 2024 and 2023:
| Nonaccrual Loans Receivable | ||||||
|---|---|---|---|---|---|---|
| Customer Tenure | As of December 31, 2024 | As of March 31, 2024 | Interest IncomeRecognized for the three months ended December 31, 2024 | Interest IncomeRecognized for the three months ended December 31, 2023 | Interest IncomeRecognized for the nine months ended December 31, 2024 | Interest IncomeRecognized for the nine months ended December 31, 2023 |
| 0 to 5 months | $14,404,816 | $13,971,062 | $152,639 | $197,470 | $521,894 | $769,418 |
| 6 to 17 months | 9,047,425 | 8,507,503 | 217,517 | 319,474 | 661,265 | 1,168,253 |
| 18 to 35 months | 11,964,366 | 12,569,729 | 346,761 | 396,720 | 1,057,869 | 1,249,102 |
| 36 to 59 months | 13,915,169 | 15,250,596 | 402,275 | 547,608 | 1,315,569 | 1,728,965 |
| 60+ months | 51,333,978 | 45,091,589 | 1,507,229 | 1,497,757 | 4,463,586 | 4,785,842 |
| Unearned interest, insurance and fees | (26,362,491) | (24,643,778) | — | — | — | — |
| Total | $74,303,263 | $70,746,701 | $2,626,421 | $2,959,029 | $8,020,183 | $9,701,580 |
As of December 31, 2024 and March 31, 2024, there were no loans receivable 61 days or more past due, not on nonaccrual status, and no loans receivable on nonaccrual status with no related allowance for credit losses.
NOTE 5 –LEASES
Accounting Policies and Matters Requiring Management's Judgment
The Company uses its senior notes payable's effective annual interest rate to determine the discount rate when evaluating leases under Topic 842. Specifically, Management applies its senior notes payable's effective annual interest rate at the end of the prior fiscal year to leases entered into in the following year. For example, the senior notes payable's annual effective interest rate of 9.9% at March 31, 2024 was used as the discount rate when determining the lease type and the present value of lease payments for leases entered into in fiscal 2025.
Based on its historical practice, the Company believes it is reasonably certain to exercise a given option associated with a given office space lease. Therefore, the Company classifies all lease options for office space as “reasonably certain” unless it has specific knowledge to the contrary for a given lease. The Company does not believe it is reasonably certain to exercise any options associated with its office equipment leases.
Periodic Disclosures
The Company's operating leases consist of real estate leases for office space as well as office equipment. Both the branch real estate and office equipment lease terms generally range from three years tofive years, and generally contain options to extend which mirror the original terms of the lease.
As of December 31, 2024 and 2023, the Company had no finance leases.
The following table reports information about the Company's lease cost for the three and nine months ended December 31, 2024 and 2023:
| Three months ended December 31, | Nine months ended December 31, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Lease Cost | ||||
| Operating lease cost | $6,387,738 | $6,163,762 | $18,846,686 | $19,000,163 |
| Variable lease cost | 940,465 | 888,119 | 2,949,878 | 2,808,845 |
| Total lease cost | $7,328,203 | $7,051,881 | $21,796,564 | $21,809,008 |
The following table reports other information about the Company's leases for the three and nine months ended December 31, 2024 and 2023:
| Three months ended December 31, | Nine months ended December 31, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Other Lease Information | ||||
| Operating cash flows for amounts included in the measurement of lease liabilities — operating leases | $6,301,091 | $6,265,527 | $18,884,883 | $18,965,468 |
| Right-of-use assets obtained in exchange for new operating lease liabilities | $3,247,250 | $4,568,169 | $13,812,021 | $13,560,648 |
| Weighted average remaining lease term — operating leases | 6.5 years | 6.9 years | 6.5 years | 6.9 years |
| Weighted-average discount rate — operating leases | 6.8% | 6.3% | 6.8% | 6.3% |
The aggregate annual lease obligations as of December 31, 2024 are as follows:
| Operating Leases | |
|---|---|
| Remainder of 2025 | $6,160,520 |
| 2026 | 22,367,057 |
| 2027 | 17,961,935 |
| 2028 | 14,520,255 |
| 2029 | 10,573,915 |
| Thereafter | 29,343,439 |
| Total undiscounted lease liability | $100,927,121 |
| Imputed interest | 19,719,824 |
| Total discounted lease liability | $81,207,297 |
The Company had no leases with related parties as of December 31, 2024 or March 31, 2024.
NOTE 6 –AVERAGE SHARE INFORMATION
The following is a summary of the basic and diluted average common shares outstanding:
| Three months ended December 31, | Nine months ended December 31, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Basic: | ||||
| Weighted average common shares outstanding (denominator) | 5,436,688 | 5,772,503 | 5,461,990 | 5,775,108 |
| Diluted: | ||||
| Weighted average common shares outstanding | 5,436,688 | 5,772,503 | 5,461,990 | 5,775,108 |
| Dilutive potential common shares | 27,529 | 87,614 | 64,794 | 121,608 |
| Weighted average diluted shares outstanding (denominator) | 5,464,217 | 5,860,117 | 5,526,784 | 5,896,716 |
Options to purchase 246,111 and 291,826 shares of common stock at various prices were outstanding during the three months ended December 31, 2024 and 2023, respectively, but were not included in diluted shares outstanding because the option exercise price exceeded the market value of the shares.
Options to purchase 250,034 and 299,904 shares of common stock at various prices were outstanding during the nine months ended December 31, 2024 and 2023, respectively, but were not included in diluted shares outstanding because the option exercise price exceeded the market value of the shares.
NOTE 7 –STOCK-BASED COMPENSATION
Stock Incentive Plans
The Company maintains the 2008 Plan, the 2011 Plan and the 2017 Plan for the benefit of certain non-employee directors, officers, and key employees. Under these plans, a total of 3,350,000 shares of authorized common stock have been reserved for issuance pursuant to grants approved by the Compensation Committee. Stock options granted under these plans have a maximum term of 10 years, may be subject to certain vesting requirements, which are generally three tosix years for officers, non-employee directors, and key employees, and are priced at the market value of the Company's common stock on the option's grant date. At December 31, 2024, there were a total of 187,020 shares of common stock remaining available for grant under the 2017 Plan.
Stock-based compensation is recognized as provided under FASB ASC Topic 718-10 and FASB ASC Topic 505-50. FASB ASC Topic 718-10 requires all share-based payments to employees, including grants of employee stock options, to be recognized as compensation expense over the requisite service period (generally the vesting period) in the consolidated financial statements based on their grant date fair values. Stock-based compensation related to restricted stock is based on the number of shares expected to vest and the fair market value of the common stock on the grant date. Stock-based compensation related to stock option awards is based on the number of shares expected to vest and the estimated fair value of the awards on the grant date using the Black-Scholes valuation model. Under the Black-Scholes valuation method, the assumptions used to determine the fair value are expected volatility, expected life, average risk-free rate, and dividend yield, if any. The expected stock price volatility is based on the historical volatility of the Company's common stock for a period approximating the expected life. The expected life represents the period of time that options are expected to be outstanding after the grant date. The risk-free rate reflects the interest rate at grant date on zero coupon U.S. governmental bonds having a remaining life similar to the expected option term.
2018 Long-term Incentive Program and Non-Employee Director Awards
On October 15, 2018, the Compensation Committee and Board of Directors approved and adopted a long-term incentive program that seeks to motivate and reward certain employees and to align management’s interest with shareholders’ interest by focusing executives on the achievement of long-term results. The program is comprised of four components: Service Options, Performance Options, Restricted Stock, and Performance Shares.
Pursuant to this program, in fiscal 2019, the Compensation Committee approved certain grants of Service Options, Performance Options, Restricted Stock and Performance Shares under the 2011 Plan and the 2017 Plan to certain employee directors, vice presidents of operations, vice presidents, senior vice presidents, and executive officers. Separately, the Compensation Committee approved certain grants of Service Options and Restricted Stock to certain non-employee directors of the Company.
Under the long-term incentive program, up to 100% of the shares of restricted stock subject to the Performance Shares will vest, if at all, based on the achievement of two trailing EPS performance targets established by the Compensation Committee that are based on EPS (measured at the end of each calendar quarter, commencing with the calendar quarter ending September 30, 2019) for the previous four calendar quarters. The Performance Shares are eligible to vest over the 2018 Performance Share Measurement Period, subject to each respective employee’s continued employment at the Company through the last day of the 2018 Performance Share Measurement Period (or as otherwise provided under the terms of the applicable award agreement or applicable employment agreement).
The Performance Share performance targets are set forth below.
| Trailing 4-Quarter EPS Targets forSeptember 30, 2018 through March 31, 2025 | Restricted Stock Eligible for Vesting(Percentage of Award) |
|---|---|
| $16.35 | 40% |
| $20.45 | 60% |
During the second quarter of fiscal 2025, it was determined that the $20.45 Performance Share performance target was no longer probable of being achieved and that the $20.45 Performance Shares would likely be forfeited as of the last day of the performance period in accordance with their terms. As a result and in accordance with ASC 718, the Company reversed $18.5 million in previously recognized stock-based compensation related to the $20.45 Performance Shares during the second quarter of fiscal 2025.
The Restricted Stock awards typically vest inthree tosix equal annual installments, beginning on the first anniversary of the grant date, subject to each respective employee’s continued employment at the Company through each applicable vesting date or otherwise provided under the terms of the applicable award agreement or applicable employment agreement.
The Service Options typically vest in three equal annual installments, beginning on the first anniversary of the grant date, subject to each respective employee’s continued employment at the Company through each applicable vesting date or otherwise provided under the terms of the applicable award agreement or applicable employment agreement. The option price is equal to the fair market value of the common stock on the grant date and the Service Options have a 10-year term.
The Performance Options will fully vest if the Company attains the trailing EPS target over four consecutive calendar quarters occurring between September 30, 2018 and March 31, 2025 as described below. Such performance target was established by the Compensation Committee and will be measured at the end of each calendar quarter commencing on September 30, 2019. The Performance Options are eligible to vest over the 2018 Performance Option Measurement Period, subject to each respective employee’s continued employment at the Company through the last day of the 2018 Performance Option Measurement Period or as otherwise provided under the terms of the applicable award agreement or applicable employment agreement. The option price is equal to the fair market value of the common stock on the grant date and the Performance Options have a 10-year term. The Performance Option performance target is set forth below.
| Trailing 4-Quarter EPS Targets forSeptember 30, 2018 through March 31, 2025 | Options Eligible for Vesting(Percentage of Award) |
|---|---|
| $25.30 | 100% |
During the second quarter of fiscal 2024, it was determined that the Performance Option performance target was no longer probable of being achieved and that the Performance Options would likely be forfeited as of the last day of the performance period in accordance with their terms. As a result and in accordance with ASC 718, the Company reversed $4.9 million in previously recognized stock-based compensation related to these Performance Options during the second quarter of fiscal 2024.
2024 Long-term Incentive Program and Non-Employee Director Awards
On December 18, 2024, the Compensation Committee and Board of Directors approved certain grants of Service Options, Performance Options, Restricted Stock and Performance Shares under the 2017 Plan to certain employee directors, vice presidents of operations, vice presidents, senior vice presidents, and executive officers. Separately, the Compensation Committee approved certain grants of Restricted Stock to certain non-employee directors of the Company.
Up to 100% of the shares of restricted stock subject to the Performance Shares will vest, if at all, based on the achievement of certain performance goals established by the Compensation Committee related to company operational performance metrics during the 2024 Performance Share Measurement Period, for which achievement must be certified by the Compensation Committee. The Performance Shares are eligible to vest over the 2024 Performance Share Measurement Period, subject to each respective employee’s continued employment at the Company through the last day of the 2024 Performance Share Measurement Period or otherwise provided under the terms of the applicable award agreement or applicable employment agreement.
The Restricted Stock awards fully vest on the first anniversary of the grant date, subject to each respective employee’s continued employment at the Company through the vesting date or otherwise provided under the terms of the applicable award agreement or applicable employment agreement.
The Service Options vest in three equal annual installments, beginning on the first anniversary of the grant date, subject to each respective employee’s continued employment at the Company through each applicable vesting date or otherwise provided under the terms of the applicable award agreement or applicable employment agreement. The option price is equal to the fair market value of the common stock on the grant date and the Service Options have a 10-year term.
Up to 100% of the Performance Options will vest, if at all, based on the achievement of certain performance goals established by the Compensation Committee related to company operational performance metrics during the 2024 Performance Option Measurement Period, for which achievement must be certified by the Compensation Committee. The Performance Options typically vest in three equal annual installments, beginning on January 30, 2026, subject to each respective employee’s continued employment at the Company through each applicable vesting date or otherwise provided under the terms of the applicable award agreement or applicable employment agreement. The option price is equal to the fair market value of the common stock on the grant date and the Performance Options have a 10-year term.
Stock Options
The weighted-average fair value at the grant date for options issued during the three months ended December 31, 2024 and 2023 was $58.29 and $68.52, respectively. The weighted-average fair value at the grant date for options issued during the nine months ended December 31, 2024 and 2023 was $58.29 and $69.00, respectively.
Fair value was estimated at grant date using the weighted-average assumptions listed below:
| Three months ended December 31, | Nine months ended December 31, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Dividend yield | —% | —% | —% | —% |
| Expected volatility | 59.53% | 62.54% | 59.53% | 62.55% |
| Average risk-free rate | 4.39% | 4.70% | 4.39% | 4.69% |
| Expected life | 4.5 years | 4.6 years | 4.5 years | 4.6 years |
Option activity for the nine months ended December 31, 2024 was as follows:
| Shares · Weighted Average ExercisePrice · Weighted AverageRemainingContractual Term · Aggregate Intrinsic Value | |||||
|---|---|---|---|---|---|
| Options outstanding, beginning of period | 267,947 | $105.77 | |||
| Granted during period | 38,661 | 111.68 | |||
| Exercised during period | (20,310) | 92.64 | |||
| Forfeited during period | (8,212) | 102.62 | |||
| Expired during period | (1,549) | 206.52 | |||
| Options outstanding, end of period | 276,537 | 2 | $107.09 | 5.1 years | $2,850,363 |
| Options exercisable, end of period | 131,659 | $110.58 | 4.6 years | $1,594,728 | |
The aggregate intrinsic value reflected in the table above represents the total pre-tax intrinsic value (the difference between the closing stock price on December 31, 2024 and the exercise price, multiplied by the number of in-the-money options that are currently exercisable) that would have been received by option holders had all option holders exercised their options as of December 31, 2024. This amount will change as the market price of the common stock changes. The total intrinsic value and tax benefit of options exercised during the three and nine month periods ended December 31, 2024 and 2023 were as follows:
| Three months ended December 31, | Nine months ended December 31, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Intrinsic value of options exercised | $215,599 | $369,543 | $732,318 | $810,853 |
| Tax benefit of options exercised | 52,822 | 90,538 | 179,418 | 198,659 |
The total fair value of stock options vested during the nine months ended December 31, 2024 was $2,120,670. As of December 31, 2024, total unrecognized stock-based compensation expense related to non-vested stock options amounted to approximately $1.9 million, which is expected to be recognized over a weighted-average period of approximately 2.5 years.
2 Of the 276,537 options outstanding,16,453 are not yet exercisable based solely on fulfilling a service condition and another 128,425 are not yet exercisable based solely on fulfilling performance conditions.
Restricted Stock
During the first nine months of fiscal 2025, the Company granted 71,186 shares of restricted stock (which are equity classified) to certain vice presidents, senior vice presidents, executive officers and non-employee directors with a grant date weighted average fair value of $111.64 per share.
During fiscal 2024, the Company granted 3,993 shares of restricted stock (which are equity classified) to certain vice presidents and senior vice presidents with a grant date weighted average fair value of $120.12 per share.
The total fair value of restricted stock vested during the nine months ended December 31, 2024 was $7,293,854. As of December 31, 2024, there was approximately $7.7 million of unrecognized compensation cost related to unvested restricted stock awards, which is expected to be recognized over the next 1.0 year based on current estimates.
A summary of the status of the Company’s restricted stock as of December 31, 2024, and changes during the nine months ended December 31, 2024, are presented below:
| Shares | Weighted Average Fair Value at Grant Date | |
|---|---|---|
| Outstanding at March 31, 2024 | 388,577 | $101.18 |
| Granted during the period | 71,186 | 111.64 |
| Vested during the period | (62,577) | 104.08 |
| Forfeited during the period | (44,566) | 100.37 |
| Outstanding at December 31, 2024 | 352,620 | $102.88 |
Total Stock-Based Compensation
Total stock-based compensation included as a component of personnel expenses in the Company's Consolidated Statements of Operations during the three and nine month periods ended December 31, 2024 and 2023 was as follows:
| Three months ended December 31, | Nine months ended December 31, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Stock-based compensation related to equity classified awards: | ||||
| Stock-based compensation (reversal) related to stock options3 | $85,640 | $189,582 | $323,140 | $(3,871,348) |
| Stock-based compensation (reversal) related to restricted stock4 | 363,626 | (690,699) | (18,886,571) | 1,475,151 |
| Total stock-based compensation (reversal) related to equity classified awards | $449,266 | $(501,117) | $(18,563,431) | $(2,396,197) |
NOTE 8 –ACQUISITIONS
The Company evaluates each set of assets and activities it acquires to determine if the set meets the definition of a business according to FASB ASC Topic 805-10-55. Acquisitions meeting the definition of a business are accounted for as business combinations while all other acquisitions are accounted for as asset purchases.
3 The $(3,871,348) for the nine months ended December 31, 2023 represents the reversal of $4.9 million in previously recognized stock-based compensation related to the Performance Options and $0.4 million in forfeiture credit, offset by $1.4 million in current period expense.
4 The $(18,886,570) for the nine months ended December 31, 2024 represents the reversal of $18.5 million in previously recognized stock-based compensation related to the $20.45 Performance Shares and $1.8 million in forfeiture credit, offset by $1.4 million in current period expense. The $(690,699) for the three months ended December 31, 2023 represents $1.4 million in forfeiture credit, offset by $0.7 million in current period expense.
The following table sets forth the Company's acquisition activity for the nine months ended December 31, 2024 and 2023:
| Nine months ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Acquisitions: | ||
| Number of loan portfolios acquired through asset purchases | 6 | — |
| Purchase price | $18,947,294 | $— |
| Tangible assets: | ||
| Loans receivable, net | 18,812,693 | — |
| Purchase price amount over carrying value of net tangible assets | $134,601 | $— |
| Customer lists | $127,995 | $— |
| Non-compete agreements | $6,606 | $— |
Acquisitions that are accounted for as business combinations typically result in one or more new branches. In such cases, the Company typically retains the existing employees and the branch location from the acquisition. The purchase price is allocated to the tangible assets and intangible assets acquired based upon their estimated fair market values at the acquisition date. The remainder is allocated to goodwill.
Acquisitions that are accounted for as asset purchases are typically limited to acquisitions of loan portfolios. The purchase price is allocated to the tangible assets and intangible assets acquired based upon their estimated fair values at the acquisition date. In an asset purchase, no goodwill is recorded. When the cost of an asset acquisition is less than the fair value of the net assets acquired, the benefit is allocated to nonmonetary long-lived assets acquired on a relative fair value basis. However, any assets for which the subsequent application of GAAP would result in an immediate gain (e.g., financial assets, assets held for sale) are not allocated a portion of the cost below fair value. Any remaining benefit is recorded as a discount on purchase, which is a component of Unearned interest, insurance and fees in the Company's Consolidated Balance Sheets, and is amortized over the life of loans receivable acquired. During the nine months ended December 31, 2024, the Company recorded a $1.0 million discount on loans acquired in asset purchases.
The Company’s acquisitions include tangible assets (generally loans and furniture and equipment) and intangible assets (generally non-compete agreements, customer lists, and goodwill), both of which are recorded at their fair values, which are estimated pursuant to the processes described below.
Acquired loans are valued at the net loan balance. Given the short-term nature of these loans, generally less than twelve months, and that these loans are priced at current rates, management believes the net loan balances approximate their fair value. Under CECL, acquired loans are included in the reserve calculations for all loan types (excluding TALs). Management includes recent acquisition activity compared to historical activity when considering reasonable and supportable forecasts as it relates to assessing the adequacy of the allowance for expected credit losses. The Company did not acquire any loans that would qualify as PCDs during the nine months ended December 31, 2024 and 2023.
Furniture and equipment are valued at the specific purchase price as agreed to by both parties at the time of acquisition, which management believes approximates their fair values.
Non-compete agreements are valued at the stated amount paid to the other party for these agreements, which the Company believes approximates their fair values.
Customer lists are valued with a valuation model that utilizes the Company’s historical data to estimate the value of any acquired customer lists.
The results of all acquisitions are included in the Company’s consolidated financial statements since the respective acquisition date. The pro forma impact of these branches as though they had been acquired at the beginning of the periods presented would not have a material effect on the results of operations as reported.
NOTE 9 –INTANGIBLE ASSETS
The following table provides the gross carrying amount and related accumulated amortization of definite-lived intangible assets:
| December 31, 2024 | March 31, 2024 | |||||
|---|---|---|---|---|---|---|
| Gross CarryingAmount | AccumulatedAmortization | Net Intangible Asset | Gross CarryingAmount | AccumulatedAmortization | Net Intangible Asset | |
| Customer lists | $55,858,615 | $(47,593,700) | $8,264,915 | $55,730,620 | $(44,796,996) | $10,933,624 |
| Non-compete agreements | 10,534,749 | (10,498,178) | 36,571 | 10,528,143 | (10,392,034) | 136,109 |
| Total | $66,393,364 | $(58,091,878) | $8,301,486 | $66,258,763 | $(55,189,030) | $11,069,733 |
The estimated amortization expense for intangible assets for future fiscal years ended March 31 is as follows: $0.9 million for the remainder of 2025; $3.2 million for 2026; $2.7 million for 2027; $0.9 million for 2028; $0.4 million for 2029; and an aggregate of $0.2 million for the years thereafter.
NOTE 10 –DEBT
Senior Notes Payable; Revolving Credit Facility
At December 31, 2024, the Company's senior notes payable consisted of a $580.0 million senior revolving credit facility, which has an accordion feature permitting the maximum aggregate commitments to increase to $730.0 million provided that certain conditions are met.
At December 31, 2024, $335.9 million was outstanding under the Company's credit facility, not including $725.8 thousand in outstanding standby letters of credit, which include (i) $300.0 thousand related to worker's compensation expiring on December 31, 2025 and (ii) $425.8 thousand related to the Company's investment in captive insurance expiring on April 12, 2025. Both letters of credit automatically extend for one year on their expiration dates. To the extent that the letter of credit is drawn upon, the disbursement will be funded by the credit facility. There are no amounts due related to the letters of credit as of December 31, 2024. Subject to a borrowing base formula, the Company may borrow at the rate of one month SOFR plus 0.10% and an applicable margin of 3.5% with a minimum rate of 4.5%. The revolving credit facility has a commitment fee of 0.50% per annum on the unused portion of the commitment. Commitment fees on the unused portion of the borrowing totaled $1.2 million and $1.3 million for the nine months ended December 31, 2024 and 2023, respectively.
For the nine months ended December 31, 2024 and fiscal year ended March 31, 2024, the Company’s effective interest rate, including the commitment fee and amortization of debt issuance costs, was 9.7% annualized and 9.9%, respectively. At December 31, 2024, the unused amount available under the revolving credit facility was $243.3 million and borrowings under the revolving credit facility mature on June 7, 2026.
Substantially all of the Company’s assets are pledged as collateral for borrowings under the revolving credit agreement.
Senior Unsecured Notes Payable
On September 27, 2021, we issued $300 million in aggregate principal amount of 7.0% senior notes due November 2026. The Notes were sold in a private placement in reliance on Rule 144A and Regulation S under the Securities Act of 1933, as amended (the "Securities Act"). The Notes are unconditionally guaranteed, jointly and severally, on a senior unsecured basis by all of the Company’s existing and certain of its future subsidiaries that guarantee the revolving credit facility. Interest on the Notes is payable semi-annually in arrears on May 1 and November 1 of each year, commencing May 1, 2022. At any time prior to November 1, 2023, the Company could have redeemed the Notes, in whole or in part, at a redemption price equal to 100% of the principal amount plus a make-whole premium, as described in the indenture, plus accrued and unpaid interest, if any, to, but not including, the date of redemption. At any time on or after November 1, 2023, the Company may redeem the Notes at redemption prices set forth in the indenture, plus accrued and unpaid interest, if any, to, but not including, the date of redemption. In addition, at any time prior to November 1, 2023, the Company could have used the proceeds of certain equity offerings to redeem up to 40.0% of the aggregate principal amount of the Notes issued under the indenture at a redemption price equal to 107.0% of the principal amount of Notes redeemed, plus accrued and unpaid interest, if any, to, but not including, the date of redemption.
We used the net proceeds from this offering to repay a portion of the outstanding indebtedness under our revolving credit facility and for general corporate purposes.
During the nine months ended December 31, 2024, the Company repurchased and extinguished $49.3 million of its Notes, net of $0.4 million unamortized debt issuance costs related to the extinguished debt, on the open market for a reacquisition price of $48.1 million.
During fiscal 2024, the Company repurchased and extinguished $15.7 million of its Notes, net of $0.2 million unamortized debt issuance costs related to the extinguished debt, on the open market for a reacquisition price of $14.1 million.
For the three months ended December 31, 2024 and 2023, the Company recognized a $50.0 thousand loss and a $0.6 million gain on extinguishment, respectively. For each of the the nine months ended December 31, 2024 and 2023, the Company recognized a $1.2 million gain on extinguishment. In accordance with ASC 470, the Company recognized the gain and loss on extinguishments as a component of interest expense in the Company's Consolidated Statements of Operations.
Debt Covenants
The agreement governing the Company’s revolving credit facility contains affirmative and negative covenants, including covenants that generally restrict the ability of the Company and its subsidiaries to, among other things, incur or guarantee indebtedness, incur liens, pay dividends and repurchase or redeem capital stock, dispose of assets, engage in mergers and consolidations, make acquisitions or other investments, redeem or prepay subordinated debt, amend subordinated debt documents, make changes in the nature of its business, and engage in transactions with affiliates. The agreement allows the Company to incur subordinated debt that matures after the termination date for the revolving credit facility and that contains specified subordination terms, subject to limitations on amount imposed by the financial covenants under the agreement. The agreement's financial covenants include (i) a minimum consolidated net worth of $325.0 million on and after December 31, 2020; (ii) a maximum ratio of total debt to consolidated adjusted net worth of 2.25 to 1.0 for the fiscal quarter ended December 31, 2023 and each fiscal quarter thereafter; (iii) a maximum collateral performance indicator of 26.0% as of the end of each calendar month; and (iv) a minimum fixed charges coverage ratio of 2.0 to 1.0 for the fiscal quarters ending December 31, 2023 through December 31, 2024, and 2.25 to 1.0 for each fiscal quarter thereafter, where the ratio for the most recent four consecutive fiscal quarters (other than for the fiscal quarter ended September 30, 2023) must be at least 2.0 to 1.0 in order for the Company to declare dividends or purchase any class or series of its capital stock or other equity.
The collateral performance indicator is equal to the sum of (a) a three-month rolling average rate of receivables at least sixty days past due and (b) an eight-month rolling average net charge-off rate.
The Company was in compliance with these covenants at December 31, 2024 and does not believe that these covenants will materially limit its business and expansion strategy.
The agreement contains events of default including, without limitation, nonpayment of principal, interest or other obligations, violation of covenants, misrepresentation, cross-default to other debt, bankruptcy and other insolvency events, judgments, certain ERISA events, actual or asserted invalidity of loan documentation, invalidity of subordination provisions of subordinated debt, certain changes of control of the Company, and the occurrence of certain regulatory events, (including the entry of any stay, order, judgment, ruling or similar event related to the Company’s or any of its subsidiaries’ originating, holding, pledging, collecting or enforcing its eligible loans receivable that is material to the Company or any subsidiary) which remains unvacated, undischarged, unbonded or unstayed by appeal or otherwise for a period of 60 days from the date of its entry and is reasonably likely to cause a material adverse change.
The indenture governing the Notes contains certain covenants that, among other things, limit the Company’s ability and the ability of its restricted subsidiaries to (i) incur additional indebtedness or issue certain disqualified stock and preferred stock; (ii) pay dividends or distributions or redeem or purchase capital stock; (iii) prepay subordinated debt or make certain investments; (iv) transfer and sell assets; (v) create or permit to exist liens; (vi) enter into agreements that restrict dividends, loans and other distributions from their subsidiaries; (vii) engage in a merger, consolidation or sell, transfer or otherwise dispose of all or substantially all of their assets; and (viii) engage in transactions with affiliates. However, these covenants are subject to a number of important detailed qualifications and exceptions.
Debt Maturities
The aggregate annual maturities of the Company's debt arrangements for future fiscal years ended March 31 are as follows:
| Amount | |
|---|---|
| Remainder of 2025 | $— |
| 2026 | — |
| 2027 | 561,249,020 |
| 2028 | — |
| 2029 | — |
| Thereafter | — |
| Total future debt payments | $561,249,020 |
NOTE 11 –INCOME TAXES
As of December 31, 2024 and March 31, 2024, the Company had $1.1 million of total gross unrecognized tax benefits including interest. Approximately $0.8 million represents the amount of net unrecognized tax benefits that are permanent in nature and, if recognized, would affect the annual effective tax rate. At December 31, 2024, approximately $0.4 million of gross unrecognized tax benefits are expected to be resolved during the next twelve months through the expiration of the statute of limitations and settlement with taxing authorities. The Company’s continuing practice is to recognize interest and penalties related to income tax matters in income tax expense. The Company had approximately $327.9 thousand accrued for gross interest as of December 31, 2024, and accrued $10.9 thousand during the nine months ended December 31, 2024.
Investment in HTC was $18.7 million and $24.8 million as of December 31, 2024 and March 31, 2024, respectively, which is included as a component of Other assets, net in the Consolidated Balance Sheets. The Company recognized net amortization from these investments of $4.2 million and $1.2 million during the three months ended December 31, 2024 and 2023, respectively, and $12.4 million and $3.2 million during the nine months ended December 31, 2024 and 2023, respectively, in income tax expense. The Company recognized tax benefits from these investments of $4.3 million and $1.2 million for the three months ended December 31, 2024 and 2023, respectively, and $13.6 million and $3.6 million for the nine months ended December 31, 2024 and 2023, respectively, in income tax expense and in Income taxes payable in the Consolidated Statements of Cash Flows. The Company did not recognize any non-tax related activity or have any significant modifications in the investments during the current period.
The Company is subject to U.S. income taxes, as well as taxes in various other state and local jurisdictions. With the exception of a few states, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2021, although carryforward attributes that were generated prior to 2021 may still be adjusted upon examination by the taxing authorities if they either have been or will be used in a future period.
The Company’s effective income tax rate increased to 16.4% for the three months ended December 31, 2024 compared to 14.6% for the prior year quarter. The increase is primarily due to the effects of provision to return adjustments treated as discrete items in the prior year quarter, which were partially offset by pretax book earnings relative to the effects of various permanent items including a decrease in the disallowed executive compensation under Section 162(m) and the recognition of additional HTCs when compared to the prior year.
NOTE 12 –COMMITMENTS AND CONTINGENCIES
From time to time the Company is involved in litigation matters relating to claims arising out of its operations in the normal course of business.
Estimating an amount or range of possible losses resulting from litigation, government actions and other legal proceedings is inherently difficult and requires an extensive degree of judgment, particularly where the matters involve indeterminate claims for monetary damages, may involve fines, penalties or damages that are discretionary in amount, involve a large number of claimants or significant discretion by regulatory authorities, represent a change in regulatory policy or interpretation, present novel legal theories, are in the early stages of the proceedings, are subject to appeal or could result in a change in business practices. In addition, because most legal proceedings are resolved over extended periods of time, potential losses are subject to change due to, among other things, new developments, changes in legal strategy, the outcome of intermediate procedural and substantive rulings and other parties’ settlement posture and their evaluation of the strength or weakness of their case against us. For these reasons, we are currently unable to predict the ultimate timing or outcome of, or reasonably estimate the possible losses or a range of possible losses resulting from, any currently pending claims. Based on information currently available, the
Company does not believe that any reasonably possible losses arising from currently pending legal matters will be material to
the Company’s results of operations or financial conditions. However, in light of the inherent uncertainties involved in such matters, an adverse outcome in one or more of these matters could materially and adversely affect the Company’s financial condition, results of operations or cash flows in any particular reporting period.
NOTE 13 –SUBSEQUENT EVENTS
Management is not aware of any significant events occurring subsequent to the balance sheet date that would have a material effect on the financial statements thereby requiring adjustment or disclosure.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.